Global Community
Our community narratives are driven by numbers and valuation.
Community Investing Ideas
Global Weekly Picks
Pfizer's Future Depends on Oncology Growth, New Products and operational efficiency
I think that Pfizer has a strong pipeline. The aquisition of seagen added many new oncology products that will continue to grow by 14% partially offseting the decline on sales of the covid-19 vaccines.Read more
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.Read more
Kaspi.kz The Dominant Super App in a Growing Digital Economy
Kaspi.kz represents a compelling investment opportunity, centered on its position as the dominant "super app" in Kazakhstan, a rapidly digitizing economy. The company's integrated ecosystem, spanning payments, marketplace, and fintech services, has fostered a loyal and engaged user base, creating a powerful network effect that drives growth and profitability, evidenced by its exceptional 80.5% Return on Invested Capital (ROIC).Read more
Steady Growth in Specialty Insurance with Capital Discipline
Main Driver of Recent Growth Palomar has delivered standout performance, with earnings growing ~61% YoY and revenue rising ~53% YoY , underscoring exceptional underwriting execution and demand momentum in specialty lines. How Catalysts Support the Trend Strong Q2 2025 results further reinforce momentum: revenue up 55% YoY and net income up 81% YoY ; earnings and revenues beat analyst expectations by ~16% and ~5% respectively.Read more
The future of Merlin lies in the management of data centers.
Merlin Propiertis is a Spanish REIT with 4 lines of business: 1. Bureaux 2.Read more
Greenwich LifeSciences will eye a valued future at $460 a share, with GP2 leading the way.
*DISCLAIMER: *This article is NOT financial advice of any kind, i am NOT a financial adviser, this content should NOT be construed as an offer, recommendation or inducement to buy or sell Greenwich Lifesciences $GLSI stock. Do yor own Due diligence with this type of products before taking from granted any of these opinions.Read more
Potential Multibagger
DRC Systems: Significant Upside Potential (Q3 FY25 - Dec 2024 Analysis) In its recent quarterly report , DRC Systems, a software product company, indicated that it expects to bag "several million dollars" in annual contracts for its newly developed software. Given the nature of the software business—where incremental costs are minimal—this revenue could have a substantial impact on the company's bottom line.Read more
Yoong Onn will trade at a 30% fair value discount to RM2.46 for long-term gains
Yoong Onn Corporation Berhad (KLSE:YOCB , Ticker 5159) In the context of fluctuating consumer spending and changing retail trends, Yoong Onn Corporation Berhad (KLSE: YOCB) is establishing itself as a resilient entity in Malaysia’s home textiles sector. The company is currently trading at a significant discount compared to analyst fair value, providing potential investors with the opportunity for long-term capital growth, solid margins, and an increasing dividend yield.Read more
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.Read more
